webinar register page

RSESS webinar: Safety of COVID-19 Therapies and Vaccines
Since the pandemic outbreak of Covid19 beginning in 2019, several vaccines have been developed to help prevent the onslaught of acute disease. In the US, three products were granted emergency use approval (EUA), including two mRNA-generated vaccinations, and one traditional vaccine generated by viral vector. The mRNA vaccinations (Pfizer-Biotech and Moderna) have been fully approved in the US. In the meantime, several therapeutics have been given EUA in the US, including Pfizer’s Paxlovid and Merck’s Molnupiravir, and monoclonal antibody treatment. The single approved drug for Covid 19 in the US is remdesivir, originally approved for Ebola, but found to have some activity against Covid 19. The webinar will focus on safety and efficacy of the approved and EUA vaccines and therapeutics for Covid 19, as well as upcoming approaches for vaccinations and therapeutics in light of the variants being found globally.

Duration: 11:00 AM - 12:30 PM ET (1.5 hours)

May 18, 2022 11:00 AM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Emily Wigginton.